See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2022_AILERON_THERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001420565')"} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 48,177,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 128,000 |
3 | remainder_Assets | 176,000 |
4 | LiabilitiesCurrent | 4,508,000 |
5 | LiabilitiesNoncurrent | 69,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 9,597,000 |
9 | ResearchAndDevelopmentExpense | 17,008,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 441,000 |
13 | remainder_ComprehensiveNetIncome | -11,000 |
yvar | yval | |
---|---|---|
0 | Assets | 48,481,000 |
1 | Liabilities | 4,577,000 |
2 | Expenses | 26,605,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 43,904,000 |
5 | NetIncome | -26,164,000 |
6 | ComprehensiveNetIncome | -26,169,500 |
7 | BaseVar | 40,057,500 |
8 | EconomicCapitalRatio | 1.86 |